R. Segreto

发表

Phosphorylation and cytoplasmic localization of MAPK p38 during apoptosis signaling in bone marrow granulocytes of mice irradiated in vivo and the role of amifostine in reducing these effects.

H. Segreto, C. Oshima, M. Franco, 2011, Acta histochemica.

Causes of unplanned interruption of radiotherapy *

R. Segreto, R. Ciconelli, Sylvia Suelotto Diegues, 2008 .

Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer

H. Segreto, R. Segreto, S. Jensen, 2012, Supportive Care in Cancer.

Low-Level Laser for Mitigation of Low Salivary Flow Rate in Head and Neck Cancer Patients Undergoing Radiochemotherapy: A Prospective Longitudinal Study.

H. Segreto, R. Segreto, A. L. S. Deboni, 2016, Photomedicine and laser surgery.

Protracted hypofractionated radiotherapy for Graves' ophthalmopathy: a pilot study of clinical and radiologic response.

H. Segreto, R. Segreto, L. Souhami, 2012, International journal of radiation oncology, biology, physics.

Clinical management of six cases of low-risk primary tonsillar non-Hodgkin's lymphoma.

R. Segreto, D. Borducchi, J. Kerbauy, 1999, Sao Paulo medical journal = Revista paulista de medicina.

Rectal Planning Risk Volume Correlation with Acute and Late Toxicity in 3-Dimensional Conformal Radiation Therapy for Prostate Cancer

R. Segreto, L. Souhami, R. S. Dias, 2011, Technology in cancer research & treatment.

Peritoneal infection by Candida albicans: study of number and size of limphocytes and phagocitic activy of peritoneal machophages in mice

Y. Juliano, N. Novo, H. Plapler, 1997 .

RTOG criteria to evaluate acute skin reaction and its risk factors in patients with breast cancer submitted to radiotherapy.

H. Segreto, R. Segreto, Ana Maria Teixeira Pires, 2008, Revista latino-americana de enfermagem.

Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables.

R. Segreto, J. Salvajoli, R. Ferrigno, 2003, International journal of radiation oncology, biology, physics.

[Mucositis in head and neck cancer patients undergoing radiochemotherapy].

H. Segreto, R. Segreto, R. S. Dias, 2011, Revista da Escola de Enfermagem da U S P.

Outcome of cerebral arteriovenous malformations after linear accelerator reirradiation

H. Segreto, R. Segreto, R. S. Dias, 2015, Surgical neurology international.

RUTHENIUM-106 BRACHYTHERAPY FOR UVEAL MELANOMAS – PRELIMINARY RESULTS : A SINGLE INSTITUTIONAL EXPERIENCE *

Segreto, R. Segreto, L. Teixeira, 2007 .

Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Brazilian Head and Neck Cancer Study Group.

R. Brentani, L. Kowalski, R. Segreto, 1998, American journal of surgery.

End results of a prospective trial on elective lateral neck dissection vs type III modified radical neck dissection in the management of supraglottic and transglottic carcinomas

R. Brentani, L. Kowalski, R. Segreto, 1999, Head & neck.

Development of granulocytes in haematopoietic tissues of Rhizoprionodon lalandii

M. Egami, R. Segreto, H. Segreto, 2002 .

Impact of low-level laser therapy on hyposalivation, salivary pH, and quality of life in head and neck cancer patients post-radiotherapy

H. Segreto, R. Segreto, M. Marcucci, 2017, Lasers in Medical Science.

Low-level laser therapy for the prevention of low salivary flow rate after radiotherapy and chemotherapy in patients with head and neck cancer*

H. Segreto, R. Segreto, A. L. S. Deboni, 2016, Radiologia brasileira.

A novel method to evaluate salivary flow rates of head and neck cancer patients after radiotherapy: a pilot study

H. Segreto, R. Segreto, M. Marcucci, 2017, Brazilian journal of otorhinolaryngology.

Spinal cord compression in beta-thalassemia: follow-up after radiotherapy.

R. Segreto, J. Kerbauy, S. F. da Fonseca, 1998, Sao Paulo medical journal = Revista paulista de medicina.

Initial care and outcome of glioblastoma multiforme patients in 2 diverse health care scenarios in Brazil: does public versus private health care matter?.

E. Victor, R. Segreto, A. J. Santos, 2014, Neuro-oncology.

Waiting time to radiotherapy as a prognostic factor for glioblastoma patients in a scenario of medical disparities.

E. Victor, R. Segreto, A. J. Santos, 2015, Arquivos de neuro-psiquiatria.

Amifostine does not prevent activation of TGFβ1 but induces smad 7 activation in megakaryocytes irradiated in vivo

H. Segreto, M. Franco, M. Silva, 2002, American journal of hematology.

THE BONE MARROW CELLS RADIOPROTECTION BY AMIFOSTINE - NN/N RATIO, APOPTOSIS, ULTRASTRUCTURAL AND LIPID MATRIX EVALUATION.

M. Egami, R. Segreto, 1999 .

Meta-analysis of long-term efficacy and safety of hypofractionated radiotherapy in the treatment of early breast cancer.

H. Segreto, R. Segreto, A. Nazário, 2019, Breast.

Importance of combined-modality therapy for primary bone lymphoma.

R. Segreto, J. Bordin, A. Alves, 2003, Leukemia & lymphoma.

Can thalidomide be effective to treat plasma cell leptomeningeal infiltration?

R. Segreto, P. Vicari, A. Arantes, 2003, European journal of haematology.

Low-level laser therapy on bone repair of rat tibiae exposed to ionizing radiation.

R. Segreto, L. Ferreira, M. D. Pereira, 2014, Photomedicine and laser surgery.

Early nuclear alterations and immunohistochemical expression of Ki-67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-beta1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma.

M. Silva, C. Oshima, M. Egami, 2004, Neoplasma.

Magnetic resonance imaging in the evaluation of standard radiotherapy field borders in patients with uterine cervix cancer

H. Segreto, R. Segreto, R. S. Dias, 2010 .

Strategies to evaluate the impact of rectal volume on prostate motion during three-dimensional conformal radiotherapy for prostate cancer*

Ana Paula Diniz Fortuna Poli, Rodrigo Souza Dias, Adelmo José Giordani, 2016, Radiologia brasileira.

Comparative analysis of dose-volume histograms between 3 D conformal and conventional non-conformal radiotherapy plannings for prostate cancer *

R. Segreto, A. Giordani, Helena Regina, 2009 .